Literature DB >> 11958838

Activation of spinal extracellular signaling-regulated kinase-1 and -2 by intraplantar carrageenan in rodents.

Alba Galan1, J Antonio Lopez-Garcia, Fernando Cervero, Jennifer M A Laird.   

Abstract

We have examined the activation of spinal extracellular signaling-regulated kinase (ERK) in juvenile rats and adult mice after intraplantar carrageenan or saline and its relationship to pain behavior. In rats, intraplantar carrageenan evoked a peak five-fold activation of spinal ERK at 30 min measured by immunoblot. Saline injection resulted in a two-fold activation. This differential ERK activation correlated with a 2.5-fold greater pain response and the development of secondary hyperalgesia in carrageenan-injected rats, whereas both saline and carrageenan produced similar primary hyperalgesia. In mice, carrageenan injection produced a peak 3.5-fold activation of ERK, but saline was ineffective. We conclude that ERK activation may underlie spinal nociceptive processing and secondary hyperalgesia after carrageenan inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958838     DOI: 10.1016/s0304-3940(02)00078-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

Review 1.  Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia.

Authors:  Theodore J Price; Fernando Cervero; Yves de Koninck
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

Review 2.  Sigma-1 receptor and inflammatory pain.

Authors:  Georgia Gris; Enrique José Cobos; Daniel Zamanillo; Enrique Portillo-Salido
Journal:  Inflamm Res       Date:  2015-04-23       Impact factor: 4.575

3.  Activation of spinal extracellular signal-regulated kinases (ERK) 1/2 is associated with the development of visceral hyperalgesia of the bladder.

Authors:  H Henry Lai; Chang-Shen Qiu; Lara W Crock; Maria Elena P Morales; Timothy J Ness; Robert W Gereau
Journal:  Pain       Date:  2011-06-25       Impact factor: 6.961

4.  Orai1 Plays a Crucial Role in Central Sensitization by Modulating Neuronal Excitability.

Authors:  Yannong Dou; Jingsheng Xia; Ruby Gao; Xinghua Gao; Frances M Munoz; Dongyu Wei; Yuzhen Tian; James E Barrett; Seena Ajit; Olimpia Meucci; James W Putney; Yue Dai; Huijuan Hu
Journal:  J Neurosci       Date:  2017-12-11       Impact factor: 6.167

5.  5-HT2A Receptor-Induced Morphological Reorganization of PKCγ-Expressing Interneurons Gates Inflammatory Mechanical Allodynia in Rat.

Authors:  Cristina Alba-Delgado; Sarah Mountadem; Noémie Mermet-Joret; Lénaïc Monconduit; Radhouane Dallel; Alain Artola; Myriam Antri
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

6.  Vanilloid receptor TRPV1-mediated phosphorylation of ERK in murine adjuvant arthritis.

Authors:  Y Chen; H H Willcockson; J G Valtschanoff
Journal:  Osteoarthritis Cartilage       Date:  2008-08-05       Impact factor: 6.576

7.  Activation of the neuronal extracellular signal-regulated kinase 2 in the spinal cord dorsal horn is required for complete Freund's adjuvant-induced pain hypersensitivity.

Authors:  Qinghao Xu; Sandra M Garraway; Amanda R Weyerbacher; Sarah J Shin; Charles E Inturrisi
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

8.  Dexmedetomidine Relieves Acute Inflammatory Visceral Pain in Rats through the ERK Pathway, Toll-Like Receptor Signaling, and TRPV1 Channel.

Authors:  Yatao Liu; Wei Liu; Xiaoqing Wang; Zhanhai Wan; Yongqiang Liu; Yufang Leng
Journal:  J Mol Neurosci       Date:  2018-09-27       Impact factor: 3.444

9.  Activation of cannabinoid receptor 2 inhibits experimental cystitis.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-20       Impact factor: 3.619

10.  SIP30 is regulated by ERK in peripheral nerve injury-induced neuropathic pain.

Authors:  Guangdun Peng; Mei Han; Yimin Du; Anning Lin; Lei Yu; Yuqiu Zhang; Naihe Jing
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.